Company Fundamentals\Company Profile
A Wright Investors' Service Research Report:
Summit Corporation Plc
440 Wheelers Farms Road
Milford, CT 06461 U.S.A.
COMPANY PROFILE
Figures in Pounds Sterling
Wright Quality Rating:LCNN Key Data
Summit Corporation plc (Summit) is a United Kingdom-based company. The Company Ticker:
is engaged in the discovery and development of new therapeutics from its Segli SUMM
technology drug discovery platform in areas of unmet medical need. On May 7, 2009,
the Zebrafish business, which was held within part of Summit (Oxford) Limited and 2011 Sales:
the whole of the subsidiary Summit Asia Pte Limited, was sold to Evotec AG. On
763,000
September 2, 2009 Dextra Laboratories Limited, the carbohydrate services business,
was sold to NZP Holding Limited. Summit (Oxford) Limited, Summit (Wales) Limited,
Summit (Cambridge) Limited and Summit Discovery 1 Limited are the subsidiaries of Major Industry:
the Company. Drugs, Cosmetics & Health
Care
Stock Chart Officers
Chairman
Dr. Barry Price Sub Industry:
Ethical Drug Manufacturers
Chief Financial Officer &
Secretary Country:
Raymond J. Spencer United Kingdom
Currency:
Pounds Sterling
Fiscal Year Ends:
January
Employees
31
Exchanges:
LON
Stock Price (8/5/2011): 6.63 p Share Type:
Recent stock performance Ordinary
1 Week -15.9%
4 Weeks -15.9%
Market Cap